• No results found

Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis Boot, J.D.

N/A
N/A
Protected

Academic year: 2021

Share "Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis Boot, J.D."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis

Boot, J.D.

Citation

Boot, J. D. (2009, September 10). Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis. Retrieved from https://hdl.handle.net/1887/13967

Version: Corrected Publisher’s Version License:

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/13967

Note: To cite this publication please use the final published version (if

applicable).

(2)

191 bibliogr aphy

bibliogr aphy

1 Belkowski SM, Boot JD, Mascelli MA, Diamant Z, de Garavilla L, Hertzog B, Polkovitch D, Towers M, Batheja A, D’Andrea MR. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease. Clin Exp Allergy. 2009; 39:

1179-1186

2 Wang WY, Boot JD, Mascelli MA, Gerth van Wijk R, Diamant Z. Comparison of biomarkers between allergic rhinitis only and allergic rhinitis with concomitant asthma. Allergy. 2009 Feb 16. [Epub ahead of print]

3 Boot JD, Chandoesing P, de Kam ML, Mascelli MA, Das AM, Gerth van Wijk R, de Groot H, Verhoosel R, Hiemstra PS, Diamant Z. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis. J Investig Allergol Clin Immunol. 2008;18(6):433-42.

4 Boot JD, de Ridder L, de Kam ML, Calderon C, Mascelli MA, Diamant Z. Comparison of exhaled nitric oxide measurements between niox mino electrochemical and Ecomedics chemiluminescence analyzer. Respir Med. 2008;102(11):1667-71.

5 Diamant Z, Boot D, Kamerling I, Bjermer L. Methods used in clinical development of novel anti-asthma therapies. Respir Med. 2008;102(3):332-8.

6 Boot JD, De Haas SL, Van Gerven JM, De Smet M, Leathem T, Wagner J, Denker A, Miller D, Van Doorn MB, Schoemaker RC, Cohen AF, Diamant Z.

MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. Pulm Pharmacol Ther. 2008;21(3):573-7.

7 Boot JD, de Kam ML, Mascelli MA, Miller B, van Wijk RG, de Groot H, Cohen AF, Diamant Z. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy. 2007;62(4):378-84.

8 Diamant Z, Boot JD, Virchow JC. Summing up 100 years of asthma. Respir Med. 2007;101(3):378-88.

9 Boot JD, de Haas S, Tarasevych S, Roy C, Wang L, Amin D, Cohen J, Sterk PJ, Miller B, Paccaly A, Burggraaf J, Cohen AF, Diamant Z. Effect of an nk1/

nk2 receptor antagonist on airway responses and inflammation to allergen in asthma. Am J Respir Crit Care Med. 2007;175(5):450-7.

10 Boot JD, Panzner P, Diamant Z. A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma. Pulm Pharmacol Ther. 2007;20(3):201-19.

11 Diamant Z, Boot JD, Tarasevych S, Fokkens WJ, de Groot H, Gerth van Wijk R. [‘Verenigde luchtwegen: implicaties voor diagnostiek en behandeling van het çombined allergic rhinitis and asthma syndrome’] Dutch. Ned Tijdschr Allergie, 2006;6:84-91.

12 Boot JD, Tarasevych S, Sterk PJ, Schoemaker RC, Wang L, Amin D, Cohen AF, Diamant Z. Reversal of the late asthmatic response increases exhaled nitric oxide. Respir Med. 2005;99(12):1591-4.

(3)

192 non - invasive sampling methods of infl ammatory biomarkers in asthma and allergic rhinitis

curriculum vitae

Johan Diderik Boot was born on October 30, 1977 in Chertsey, England. After graduating from secondary school (Christelijk Gymnasium Sorghvliet, The Hague, 1995) he started studying Biopharmaceutical Sciences at the Leiden University in 1996. A research project was performed on antisense therapy for atherosclerosis at the Leiden Amsterdam Centre for Drug Research (Department of Biopharmacy; Prof T. van Berkel) and an internship at the Fortis capital markets & corporate finance Biotech team was completed.

A Master of Science degree was obtained in 2002. After briefly working for Sanofi-Synthelabo in the clinical research department he took on the position of clinical scientist at the Centre for Human Drug Research (chdr;

ceo Prof. Dr. A.F. Cohen) in 2003. The research described in this thesis was

performed at chdr. In 2009 the registration as a clinical pharmacologist was

obtained. Currently he works for Nycomed bv, Hoofddorp, The Netherlands

as Medical Manager.

Referenties

GERELATEERDE DOCUMENTEN

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Inversely, a nasal aller- gen challenge in non-asthmatics with allergic rhinitis resulted in increased expression of adhesion molecules and uptake of eosinophils in the bronchial

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

In the present study of patients with allergic rhinitis, we tested the reproduc- ibility of several inflammatory biomarkers obtained by semi-invasive sam- pling techniques in

Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

De klachten die patiënten met astma en/of allergische rhinitis uiten, zijn verschillend per patiënt, en kunnen gepaard gaan met de volgende symptomen: kortademigheid,

5 Cleaved slpi reflects mast cell chymase activity in vivo and hence, may serve as a biomarker of allergic airway inflammation in both the upper and lower airways (this thesis). 6